In hepatocellular carcinoma, IGFBP4 as a novel tumor suppressor potently inhibits cell proliferation, invasion, and diminishes xenograft tumor growth in mice by the EZH2 and AKT pathways [32]. The gene discussed is AKT1; the disease is hepatocellular carcinoma.